Advances in the Treatment of Spinal Muscular Atrophy

Expanding Myasthenia Gravis Treatment With Newly Approved Therapy Nipocalimab: Nicholas J. Silvestri, MD, FAAN

FDA AdComm Plans to Review Investigational Cell Therapy Deramiocel for DMD Cardiomyopathy

Personalizing Treatment Plans for Patients With PD

NeurologyLive® and CMSC Announce the Fourth Class of Giants of Multiple Sclerosis® Inductees